BioLineRx is a commercial-stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases. Headquartered in Israel, with operations in the U.S., BioLineRx is driving innovative therapeutics with end-to-end expertise in drug development and commercialization, ensuring life-changing discoveries move beyond the bench to the bedside.

The company is advancing a pipeline of investigational medicines for patients with multiple myeloma, sickle cell disease, pancreatic cancer, and other solid tumors.

Corporate Presentation

Shape Shape
Potential life-changing treatments are on the way

Each molecule in our development pipeline is carefully selected for its potential ability to improve upon the standard of care, delivering maximum value to patients